07-Aug-2026Today's Market Indicators


Venmax Drugs used Rs 20.05 crore from warrant issue for working capital and acquisitions
(18:28, 07 Aug 2026)
Venmax Drugs & Pharmaceuticals Limited stated there was no deviation or variation in the use of Rs 20.05 crore raised through the issue of fully convertible equity warrants on a preferential basis, according to a regulatory filing with the BSE Limited on August 7, 2026; Rs 12.69 crore was received against 63,44,000 warrant conversions and Rs 1.84 crore against 36,81,000 warrant conversions, with Rs 8.37 crore utilized for working capital and Rs 0.20 crore for general corporate purposes and business acquisition as of June 30, 2026.